Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 1, 2017, after the close
10-Q filed Aug 1, 2017, 32 days after period end · 0001558370-17-005590
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$19.15M | — | — | — |
| EPS Diluted | -$0.16 | -$0.15 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.16 |
| -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
